Protection against laryngeal and pharyngeal carcinoma: Heterozygous vs. homozygous deletions of GSTM1 and GSTT1
- PMID: 23569401
- PMCID: PMC3615511
- DOI: 10.1590/S1415-47572013005000006
Protection against laryngeal and pharyngeal carcinoma: Heterozygous vs. homozygous deletions of GSTM1 and GSTT1
Abstract
Deletions in GSTM1 and GSTT1 genes are considered to be a risk factor for cancer development but the exact location of these deletions in the genome was unknown. Three main objectives of the current study were to: (a) identify the boundaries of these deletions in the human genome, (b) screen homozygous (-/-) and heterozygous (+/-) deleted, as well as homozygous present (+/+) individuals using PCR assays, (c) detect associations of pharyngeal (PC) and laryngeal cancer (LC) with the respective genotypes. In total, 102 PC and 92 LC patients were screened and compared with 150 controls. PCR mapping and sequencing revealed a 6 kbp deletion for GSTM1 and a 9 kbp deletion for the GSTT1 gene. The mean age of PC cases was 48.1 (±16.7) years; for LC cases it was 48.5 (±17.4) years and for controls 46 (±17.7) years. The OR (odds ratio) for the GSTM1 null genotype in PC and LC cases was 10.2 and 1.0 (95% CI 5.04-20.7 and 1.1-1.7) respectively. Similarly, for GSTT1 the OR was 4.02 with a 95% CI of 2.3-7.1 in PC cases. For LC cases the OR was 0.8 with 95% CI of 0.4-1.7. A non-significant number of LC and PC patients had heterozygous deletions of GSTM1 compared to controls (OD 0.5, 95% CI 0.2- 1.6 and OR 0.5, 95% CI 0.2- 1.5 respectively). The GSTT1 gene also showed a non-significant association in PC (OD 0.9, 95% CI 0.4-1.9), as well as in LC patients (OD 0.7, 95% CI 0.3-1.7). The homozygous genotype was significantly associated with PC and LC, whereas the heterozygous was not so. The GSTM1 (-/-) and GSTT1 (-/-) genotypes are a risk factor for LC and PC, whereas the (+/-) genotypes are not.
Keywords: GSTM1; GSTT1 heterozygous; cancer; deletions; homozygous.
Figures


Similar articles
-
Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.BJU Int. 2011 Jun;107(11):1825-32. doi: 10.1111/j.1464-410X.2010.09683.x. Epub 2010 Oct 13. BJU Int. 2011. PMID: 20942828
-
GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):73-80. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667466
-
Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.Neoplasma. 2006;53(4):309-15. Neoplasma. 2006. PMID: 16830058
-
Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.Cancer Epidemiol Biomarkers Prev. 1997 Sep;6(9):733-43. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9298582 Review.
-
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.Oncotarget. 2017 Jan 10;8(2):3246-3258. doi: 10.18632/oncotarget.13702. Oncotarget. 2017. PMID: 27911277 Free PMC article.
Cited by
-
Genetic variations and head and neck cancer risks.Mol Biol Rep. 2014;41(4):2667-70. doi: 10.1007/s11033-014-3125-6. Epub 2014 Jan 23. Mol Biol Rep. 2014. PMID: 24452716 Review.
-
Absence of Glutathione S-Transferase Theta 1 Gene Is Significantly Associated With Breast Cancer Susceptibility in Pakistani Population and Poor Overall Survival in Breast Cancer Patients: A Case-Control and Case Series Analysis.Front Oncol. 2021 Dec 6;11:678705. doi: 10.3389/fonc.2021.678705. eCollection 2021. Front Oncol. 2021. PMID: 34938652 Free PMC article.
-
Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis.Tumour Biol. 2014 Sep;35(9):8781-5. doi: 10.1007/s13277-014-2121-8. Epub 2014 May 31. Tumour Biol. 2014. PMID: 24879623
-
Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients.Bone Marrow Transplant. 2016 Mar;51(3):377-83. doi: 10.1038/bmt.2015.321. Epub 2015 Dec 21. Bone Marrow Transplant. 2016. PMID: 26691424 Free PMC article. Clinical Trial.
-
Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses.BMC Cancer. 2024 Jul 22;24(1):885. doi: 10.1186/s12885-024-12618-7. BMC Cancer. 2024. PMID: 39039477 Free PMC article.
References
-
- Acar H, Kayhan O, Hamza MM, Selmon MY, Tulin C, Oguz C, Ozer B. Relation of glutathione S transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk. Cancer Genet Cytol. 2006;169:89–93. - PubMed
-
- Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, van Duijn CM, Paludetti G, et al. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol. 2008;134:93–100. - PubMed
-
- Bongers V, Snow GB, Braakhuis BJ. The role of glutathione S-transferases in head and neck squamous cell carcinogenesis. Eur J Cancer B Oral Oncol 31B. 1995;6:349–354. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous